Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Biochemical and Biophysical Research Communications|June 12, 2016
Generation and characterization of a human-mouse chimeric antibody against the extracellular domain of claudin-1 for cancer therapy using a mouse modelYosuke Hashimoto, Minoru Tada, Manami Iida, et al.
American Journal of Physiology. Cell Physiology|November 29, 2024
Suppression of Dad1 induces cardiomyocyte death by weakening cell adhesionShota Mori, Rumi Kimura, Hirofumi Morihara, et al.
Protein Expression and Purification|June 24, 2008
Ligand-independent assembly of purified soluble magic roundabout (Robo4), a tumor-specific endothelial markerMai Yoshikawa, Yohei Mukai, Yoshiaki Okada, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 12, 2021
Safety and efficacy of an anti-claudin-5 monoclonal antibody to increase blood-brain barrier permeability for drug delivery to the brain in a non-human primateKeisuke Tachibana, Yosuke Hashimoto, Keisuke Shirakura, et al.
Biochemical and Biophysical Research Communications|October 14, 2015
Expression of the Robo4 receptor in endothelial cells is regulated by two AP-1 protein complexesYoshiaki Okada, Hiroki Naruse, Toru Tanaka, et al.
The Journal of Biological Chemistry|September 19, 2006
A novel class of vascular endothelial growth factor-responsive genes that require forkhead activity for expressionMd Ruhul Abid, Shu-Ching Shih, Hasan H Otu, et al.
Biochemical and Biophysical Research Communications|February 21, 2012
Embryonic stem cell differentiation system for evaluating gene functions involved in physiological megakaryocytic differentiationYoshiaki Okada, Masaaki Yonekura, Miho Watanabe, et al.
Biological & Pharmaceutical Bulletin|April 7, 2017
Tumor Necrosis Factor α Induces the Expression of the Endothelial Cell-Specific Receptor Roundabout4 through the Nuclear Factor-κB PathwayToru Tanaka, Naoki Maekawa, Taito Kashio, et al.
Biological & Pharmaceutical Bulletin|December 3, 2023
Arid5a/IL-6/PAI-1 Signaling Is Involved in the Pathogenesis of Lipopolysaccharide-Induced Kidney InjuryKoki Tanaka, Hiroki Harada, Hiroyasu Kamuro, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 21, 2017
Creation of a Claudin-2 Binder and Its Tight Junction-Modulating Activity in a Human Intestinal ModelMutsumi Takigawa, Manami Iida, Shotaro Nagase, et al.
Pageof 14